The laws regulating the pharmaceutical market in Moldova are flawed and don’t meet European standards. Liberal MP Gheorghe Brega, head of the inquiry commission for the examination of the situation on the pharmaceutical market, told Info-Prim Neo that a bill was being prepared for the modification of the legal framework in the field. The commission will finalize its works on December 1 and its head says he is preparing a report on the situation in this domain. “The main conclusion is that we must amend the legislation. There are seven laws that need amendments or modifications. There are problems in each direction and there are gaps that allow actions that are hardly beneficial”, said Brega. A study of the Moldovan pharmaceutical market revealed there were some arrangements in this field. According to the parliamentarian, after it was created in May, the commission initiated multiple inspections, the first of which was at the Medicine Agency. In September, Gheorghe Brega accused a company of having managed to register 137 drugs in a year, sometimes 40 in a month, while other companies only register 5 or 6 per year. The commission found some irregularities in the organization of tenders for the procurement of drugs in public medical institutions.